Home > Search Results: Hu, Xixi
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
15 p, 1.4 MB Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial / Bar-Or, Amit (University of Pennsylvania) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Hu, Xixi (Novartis) ; Kropshofer, Harald (Novartis) ; Kukkaro, Petra (Novartis) ; Coello, Neva (Novartis) ; Ludwig, Inga (Novartis) ; Willi, Roman (Novartis) ; Zalesak, Martin (Novartis) ; Ramanathan, Krishnan (Novartis) ; Kieseier, Bernd C. (Novartis) ; Häring, Dieter A. (Novartis) ; Bagger, Morten (Novartis) ; Fox, Edward (University of Texas) ; Universitat Autònoma de Barcelona
Introduction: Several studies have described prognostic value of serum neurofilament light chain (sNfL) at the group level in relapsing multiple sclerosis (RMS) patients. Here, we aimed to explore the temporal association between sNfL and development of subclinical disease activity as assessed by magnetic resonance imaging (MRI) at the group level and evaluate the potential of sNfL as a biomarker for capturing subclinical disease activity in individual RMS patients. [...]
2023 - 10.1007/s40120-022-00427-8
Neurology and Therapy, Vol. 12 Núm. 1 (2023) , p. 303-317  
Detailed record - Creative Commons
2.
18 p, 436.4 KB COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introduction: The SARS-CoV-2 pandemic necessitated better understanding of the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report characteristics of COVID-19 cases and vaccination status in ofatumumab-treated relapsing multiple sclerosis (RMS) patients. [...]
2022 - 10.1007/s40120-022-00341-z
Neurology and Therapy, Vol. 11 Núm. 2 (june 2022) , p. 741-758  
Detailed record - Creative Commons
3.
4 p, 243.1 KB Correction to : COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
2022 - 10.1007/s40120-022-00346-8
Neurology and Therapy, Vol. 11 Núm. 2 (2022) , p. 759-762  
Detailed record - Creative Commons

See also: similar author names
62 Hu, X.
1 Hu, X.S.
1 Hu, Xianmin
1 Hu, Xiao
1 Hu, Xiaofan
1 Hu, Xiaoteng
1 Hu, Xiaoxiang
1 Hu, Xintao
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with